Alzchem Group Ag Stock Net Income
| ALZCF Stock | USD 166.85 0.00 0.00% |
Fundamental analysis of AlzChem Group allows traders to better anticipate movements in AlzChem Group's stock price by examining its financial health and performance throughout various phases of its business cycle.
AlzChem |
AlzChem Group AG Company Net Income Analysis
AlzChem Group's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current AlzChem Group Net Income | 27.59 M |
Most of AlzChem Group's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AlzChem Group AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, AlzChem Group AG reported net income of 27.59 M. This is 329.28% lower than that of the Basic Materials sector and 93.47% lower than that of the Specialty Chemicals industry. The net income for all United States stocks is 95.17% higher than that of the company.
AlzChem Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AlzChem Group's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of AlzChem Group could also be used in its relative valuation, which is a method of valuing AlzChem Group by comparing valuation metrics of similar companies.AlzChem Group is currently under evaluation in net income category among its peers.
AlzChem Fundamentals
| Return On Equity | 0.27 | |||
| Return On Asset | 0.0508 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 276.28 M | |||
| Shares Outstanding | 10.14 M | |||
| Shares Owned By Insiders | 52.92 % | |||
| Shares Owned By Institutions | 22.75 % | |||
| Price To Earning | 9.34 X | |||
| Price To Book | 2.89 X | |||
| Price To Sales | 0.52 X | |||
| Revenue | 422.29 M | |||
| Gross Profit | 258.3 M | |||
| EBITDA | 62.69 M | |||
| Net Income | 27.59 M | |||
| Cash And Equivalents | 6.91 M | |||
| Cash Per Share | 0.68 X | |||
| Total Debt | 37.55 M | |||
| Current Ratio | 1.93 X | |||
| Book Value Per Share | 13.74 X | |||
| Cash Flow From Operations | 43.02 M | |||
| Earnings Per Share | 2.96 X | |||
| Number Of Employees | 1.48 K | |||
| Beta | 1.16 | |||
| Market Capitalization | 280.15 M | |||
| Total Asset | 377.67 M | |||
| Z Score | 5.2 | |||
| Net Asset | 377.67 M | |||
| Last Dividend Paid | 1.0 |
About AlzChem Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AlzChem Group AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AlzChem Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AlzChem Group AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in AlzChem Pink Sheet
AlzChem Group financial ratios help investors to determine whether AlzChem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AlzChem with respect to the benefits of owning AlzChem Group security.